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Jerne (1) has proposed that the immune system functions as an interacting network 
of inducible  elements  that  normally  exist  in  a  steady  state.  In  this  network,  the 
immune response is regulated by idiotype-anti-idiotype interactions. Antigen admin- 
istration stimulates some elements of the network, and the subsequent alterations to 
restore  the  perturbed  steady-state  condition  represent  the  cellular  and  molecular 
reactions that occur during the immune response. 
In many experimental systems that examine idiotype-anti-idiotype interactions, the 
anti-idiotypic antibodies  have been induced  in species other than  the one in which 
the idiotype was produced (2-6). Induction of isologous anti-idiotypic antibodies has 
also been achieved (4-12).  Spontaneous, autologous anti-idiotypic-antibody and (or) 
anti-receptor-antibody production during the course of an immune response has been 
described for haptens (13-16), sheep erythrocytes (SRBC) 1 (i 5,  16), and alloantigens 
(16-19).  In  addition,  the  decrease  in  binding  affinity of anti-tobacco mosaic virus 
antibodies has been attributed  to the appearance, during the course of the immune 
response, of lymphocytes bearing auto-anti-idiotypic receptors (20). 
Although cyclic changes in serum-antibody levels and affinity have been observed 
during the immune response to many antigens, they have generally been attributed 
to variations in the degree of masking, by serum antibody, of antigenic determinants 
on persisting antigen  (21, 22). Nevertheless, a rapid decrease in affinity of individual 
plaque-forming cells  (PFC)  (23)  or serum antibody (20,  24)  cannot be convincingly 
explained  in  this  manner.  Urbain  (25)  has  suggested  that  an  auto-anti-idiotypic 
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response is responsible for such affinity changes. The decrease in the PFC response to 
Pneumococcus R36A vaccine and the subsequent increase in the number of anti-idiotype- 
specific PFC may also reflect idiotypic-anti-idiotype interactions  (13,  14, 26). 
In recent studies on the immune response of AKR/J  mice to 2,4,6-trinitrophenyl- 
lys-Ficoll  (TNP-F),  a  precipitous  decrease in  PFC numbers,  as well  as a  decrease in 
antibody affinity and  heterogeneity, were noted after the peak of the response  (27). 
This decrease in the magnitude of the PFC response occurred much more rapidly and 
was more marked than that observed during the response to haptens on T-dependent 
(28), or T-independent,  carriers  (29-31)  in other strains.  In a  further analysis of this 
phenomenon, it was observed that under certain circumstances, contrary to expecta- 
tion, the addition  of hapten to a  PFC assay resulted  in an increase in the number of 
anti-hapten  PFC  detected,  suggesting the displacement,  by hapten,  of bound  auto- 
anti-idiotypic  antibody from the surface of antibody-synthesizing cells.  The data  to 
be reported  here and in the companion paper  (32)  support the hypothesis that auto- 
anti-idiotypic antibody, produced during the course of the immune response, combines 
with cell-surface antigen receptors and inhibits antibody secretion. 
Several  observations  that  can  be  readily  interpreted  by  this  hypothesis  will  be 
presented.  They include:  (a) the very rapid decline in the number of PFC that occurs 
early in  the  immune  response  of AKR/J  mice to TNP-F;  (b)  the disappearance  of 
high-affinity PFC associated with a  decrease in average affinity during the primary 
response to TNP-F;  (c)  the occurrence after day 4 of the primary response to TNP-F 
of blocked  anti-2,4,6-trinitrophenol  (TNP)  antibody-secreting  cells  that  can  be  de- 
tected as PFC only in the presence of hapten; and  (d) the observation that both cells 
and serum  from TNP-F immune mice can suppress  the response of normal  mice to 
this antigen by blocking a  large percentage of antibody-forming cells. 
Materials  and Methods 
Animals.  Adult  male  BALB/c  and  AKR/J  mice  were  purchased  from  Charles  River 
Breeding Laboratories,  Inc., Wilmington,  Mass.  and  The Jackson Laboratory, Bar  Harbor, 
Maine, respectively. 
Antigens and Haptens.  TNP-F was prepared by coupling TNP-lysine (Sigma Chemical Co., 
St. Louis, Mo.) to Ficol1400 (F, Pharmaeia Fine Chemicals, Div. of Pharmaeia Inc., Piscataway, 
N.J.) (33), and quantified by optical-density measurement at 348 nm (34) and dry weight. The 
haptens,  2,4-dinitrophenyl-E-amino-n-caproic acid  (DNP-EACA)  and  2,4,6-trinitrophenyl-e- 
amino-n-caproic acid (TNP-EACA), were prepared and quantified as described (34, 35). 
Immunization.  Mice were immunized intravenously with  10/~g TNP-F. Animals were bled, 
were killed by cervical dislocation, and their spleens were assayed for anti-TNP PFC at various 
intervals. 
Plaque Assay.  Cell suspensions were prepared  from individual spleens,  were washed once, 
and were resuspended in Hanks' balanced salt solution  (Grand Island Biological Co., Grand 
Island, N. Y.). Direct splenic anti-TNP PFC were assayed by the method of  Jerne and Nordin 
(36)  as  modified  for  slide  assay  by  Dresser  and  Greaves  (37).  Trinitrophenylated  sheep 
erythrocytes (TNP-SRBC) were used as indicator cells (28). Normal guinea pig serum, absorbed 
with SRBC, was the complement (C) source. On occasion, indirect PFC were also enumerated 
(38). 
Assay of Affinity  ofAnti-TNP PFC.  The affinity distribution of anti-TNP PFC was assayed 
by the inhibition of plaque formation as described previously (39-41). Concentrations of DNP- 
EACA or TNP-EACA in the agarose and C ranged from 1 ×  10  -9 to 1 ×  10  -5 M  in half-log 
increments  (42).  The Shannon heterogeneity index  (42)  was used  to describe  the degree of 
heterogeneity of affinity of the PFC population from individual mice. 
Cell and Serum Transfer.  1.2-4.0  ×  10  7 viable spleen cells from normal or immune mice were 140  AUTO-ANTI-IDIOTYPIC ANTIBODY 
transferred, intravenously, together with 10 #g TNP-F into syngeneic, nonirradiated recipients. 
For serum transfers,  normal mice received  1 ml of normal serum, or day-7 immune anti-TNP- 
F  antiserum,  intraperitoneally,  2-3  h  before  the  intravenous  injection  of  10  #g  TNP-F. 
Recipients  were  killed  3-4  d  later  and  splenic  anti-TNP  PFC  were  determined.  In  some 
experiments, irradiated recipients were also included  (Gammator Irradiator, Radiation Ma- 
chinery Corp., Parsippany, N.J., 520 rad/min, Cs source). T cells were depleted from the donor 
cells by treatment with anti-Thy 1.1 antisera plus nontoxic rabbit C (43). Anti-Thy 1.1 antisera 
was prepared by repeated immunization of C3H  mice with thymocytes from AKR/J mice 
(titer on  AKR/J  thymocytes and  spleen  cells was  1:600 and  1:60, respectively).  On  some 
occasions, rabbit anti-mouse brain antisera (RAMB) was used for T-cell depletion of the donor 
population (44). Both anti-Thy 1.1 antisera and RAMB gave similar results in the cell transfers. 
Sera from donor mice were titrated for anti-TNP antibody by passive hemagglutination with 
TNP-SRBC (average titer on day 7,  1:5,000). 
Results 
Hapten Augmentation of Plaque Formation.  During a study of the immune response of 
AKR/J  and BALB/c mice to TNP-F, an unusually rapid decline in the number of 
PFC was observed between days 4 and  7 after antigen injection,  particularly in the 
AKR/J strain (Fig.  1). A switch to 7S PFC was not responsible for this phenomenon 
because the number of indirect  PFC  (or  7S  PFC  detected  in  the presence of anti-# 
chain antibody) was generally lower than the number of direct PFC. To determine if 
specific immune suppression was responsible for this decline, nonimmune spleen cells 
or spleen cells taken  7 d  after immunization  were transferred into normal, nonirra- 
diated, syngeneic mice together with TNP-F. Recipient spleen cells were assayed for 
anti-TNP PFC 3 or 4 d later. The magnitude of the response was determined and the 
heterogeneity of the  PFC  with  respect  to the affinity of the antibody produced  by 
individual  cells  was  assayed  by  hapten  inhibition  of plaque  formation.  AKR/J 
recipients of immune spleen cells showed significantly lower PFC responses than did 
control mice (Table I). However, when the assay for antibody affinity was performed, 
the addition of hapten had an unexpected effect. Although the recipients of normal 
cells showed the usual  progressive inhibition  of plaque formation in the presence of 
increasing  hapten  concentrations,  the patterns obtained  with  spleen  cells  from the 
experimental group showed a  marked augmentation of PFC at intermediate hapten 
concentrations  (Fig. 2). Although the percentage of augmentation was higher on day 
3 than on day 4, the total number of hapten-augmentable PFC was higher on day 4 
(Table I). 
This augmentation  of plaque formation was seen over a  limited range of hapten 
concentrations  (3  ×  10-9-10  -7 M  TNP-EACA).  As indicated  in Table I, the peak 
number of PFC  observed in  the presence of hapten  averaged two-three times  that 
observed  in  the  absence  of  hapten.  In  individual  recipients  from  four  different 
experiments, the percentage of augmentation ranged from 41 to 445%. Augmentation 
of PFC by free hapten  (10-7-10  -6 M)  was also seen with spleen cells from BALB/c 
recipients of day-14 immune syngeneic spleen cells, although the degree of augmen- 
tation was less than  that observed with AKR/J  mice (data not shown).  No hapten 
augmentation of PFC was observed in BALB/c recipients of day-7 immune cells. In 
a  similar series of experiments, hapten augmentation of PFC was seen in irradiated 
AKR/J  recipients of day-7 syngeneic immune spleen cells (2,500 PFC in the absence 
of hapten,  8,600  PFC  in  the  presence  of optimal  hapten  concentrations).  As  the 
magnitude of the PFC response was much lower than that of nonirradiated recipients, F.  SCHRATER,  E.  GOIDL, J.  THORBECKE,  AND  G.  SISKIND 
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FIe.  1.  Kinetics of the  PFC  response to TNP-F  in  AKR/J  and  BALB/c  mice.  Animals were 
immunized by the  intravenous injection  of 10 #g TNP-F.  Data are reported as mean  :t:  SE for 
groups of 8-30 mice. 
it was concluded that the majority of the PFC in the cell-transfer experiments with 
normal recipients were probably of recipient origin. 
If one calculates the magnitude of the response in terms of the maximum number 
of PFC detected in the presence of hapten, it is clear that the decrease in the number 
of antibody-synthesizing cells observed in recipients of immune cells (Table I)  was 
only apparent. Thus, in the presence of hapten, the average number of PFC/spleen 
in the recipients of immune cells was equal to, or higher than, control values. 
The fine specificity of hapten augmentation of anti-TNP PFC was examined by 
comparing the effect of TNP-EACA with  that  of the cross-reactive hapten,  DNP- 
EACA  (Fig.  3).  The degree of augmentation  was  less  with  DNP-EACA  than with 
TNP-EACA, and  higher concentrations of DNP-EACA were required for augmen- 
tation of PFC.  Thus,  the cross-reactive hapten,  2,4,-dinitrophenol  (DNP),  was  less 
effective than TNP in releasing the PFC from suppression. 
B-cell Role in the Regulatory Effects of Immune Spleen Cells.  The treatment of immune 
spleen cells with RAMB or with anti-Thy 1.1 antisera plus C, before transfer, failed 
to eliminate the hapten  augmentation  of the recipients' PFC.  Furthermore, rather 
than a decrease in the magnitude of the PFC response, there was an increase over the 
control response by recipients of normal cells (Fig. 2 and Table II). These observations 
implied that  this form of regulation, and, in particular, the appearance of hapten- 
augmentable PFC, was not mediated solely by T  cells, although they did appear to 142  AUTO-ANTI-IDIOTYPIC ANTIBODY 
TABLE I 
Apparent Inhibition of the Primary Response to TNP-F in Normal Recipients of Syngeneic Immune 
Cells and Reversal by the Presence of Hapten in the Agarose during the PFC Assay 
Direct anti-TNP PFC per spleen  Percentage 
Donor cells*  Assay  augmenta- 
day  Assayed with hapten ab-  Assayed with hap-  tion by 
sent  ten present  hapten:~ 
Normal spleen  3  39,800 +  ×  1.11 (10)  46,800 +X 1.13 
Immune spleen  3  11,200 +  ×  1.30 (7)  44,700 +X 1.14 
(day 7) 
Normal spleen  4  112,000 +  ×  1.26 (11)  120,200 +X 1.26 
Immune spleen  4  67,600 +  ×  1.29 (11)  149,900 +X 1.17 
(day 7) 
% 
17 
298 
7 
122 
* 4 ×  107 spleen cells from normal or immune AKR/J mice were transferred, together with 10 ~g 
TNP-F, into normal AKR/J mice (day 0). Immune donors had been injected with 10 ~g TNP-F 
7 d previously. Direct anti-TNP PFC were assayed 3 or 4 d after cell transfer as indicated.  The 
data are presented as geometric means ×/+ SE (number of animals studied). Results summarize 
the data obtained from five independent experiments. 
:~ Percentage  augmentation of PFC by optimal hapten concentration  (3  ×  10-g-10  -7 M  TNP- 
EACA) is calculated as: 100 ×  (PFC in presence of hapten -  PFC in absence of hapten)/PFC in 
absence of hapten. 
have an important role. T-depleted, primed B cells apparently had two effects on the 
response of recipients: (a) they increased the anti-TNP PFC response to TNP-F, and 
(b)  they  controlled  the  appearance  of hapten-augmentable  PFC.  Because  of these 
findings  and  of the  rigorous  hapten  specificity  (Fig.  3),  it  seemed  probable  that 
appearance  of hapten-augmentable  PFC  was  mediated  by  a  B-cell product,  most 
likely, under T-cell control. 
Therefore,  it  was  determined  whether  serum  from  day-7  immune  AKR/J  mice 
could also affect  the response of normal  recipients to TNP-F.  Injection of immune 
serum into normal mice at the time of immunization caused a decrease in the number 
of PFC/spleen  (Table  II). This  depression was  similar to  the apparent  decrease in 
PFC observed after immune-cell transfer, in that it was reversible by hapten. Because 
the response of the  immune-serum-treated  mice was  low  for a  day-3 response even 
after hapten augmentation,  an additional inhibition of the immune response due to 
the high anti-TNP-antibody titer of the serum was likely (45, 46). 
It  was  concluded  that  a  serum  factor,  as  well  as  immune  cells,  could  cause  a 
spurious inhibition of the PFC response. It was also concluded that although B  cells 
were a  major contributor to the regulatory effect, the presence of immune T  cells in 
the transferred-cell population increased the degree of apparent suppression. 
Hapten-Augmentable PFC Occur Spontaneously in Spleens of Normal Mice during the Immune 
Response to TNP-F.  It was argued that if auto-anti-idiotypic interactions were respon- 
sible for  the  suppression  observed  after  immune-spleen-cell and  serum  transfers,  a 
similar apparent suppression of PFC might occur during the normal immune response 
in the donor animals. A  temporal study was  therefore carried out  on  the ability of 
hapten  to  inhibit  or  augment  the  apparent  number  of anti-TNP  PFC  present  at F. SCHRATER,  E. GOIDL, J. THORBECKE,  AND  G. SISKIND 
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The splenic PFC response and presence of hapten-augmentable PFC in AKR/J recipients 
of anti-Thy 1.1 antisera plus C treated syngeneic  immune donor spleen  cells. The anti-TNP PFC 
responses of all recipients were determined 4 d after intravenous injection of donor cells plus 10 lag 
TNP-F. The number of PFC/spleen is indicated on the abscissa. The effect of TNP-EACA on the 
number of PFC  is indicated by the hatched bars.  Hapten  concentration  increases  to the right. 
Maximum percentage augmentation of PFC by hapten is written at the top of the relevant bar in 
the histogram. The number of PFC in the absence of hapten is indicated by the open bar. Panel A: 
recipients of 4  ×  107 normal spleen cells; Panel B: recipients of 4  ×  10  7 immune spleen cells; Panel 
12: recipients of 2.6  X  10  7 anti-Thy-l.1  antisera-treated  immune spleen cells.  10  7 cells/ml were 
incubated with C (1:18) alone or together with anti-Thy 1.1 (1:60), for 45 rain at 37"C. The number 
of ceils transferred is the number of viable cells present (out of an initial 4.5  ×  10  7 cells/recipient) 
after treatment with these reagents.  Immune donor cells were obtained from AKR/J mice 7 d after 
intravenous injection of 10 lag TNP-F. 
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various times after the injection of TNP-F.  The frequency and the degree of augmen- 
tation of PFC  are reported  in Table  III.  In both strains  of mice studied,  there was  a 
low  incidence  (17-22%)  of animals  having  detectable  hapten-augmentable  PFC  on 
day  4, the peak of the  PFC  response.  The  incidence increased  to 60%  by day  5  and, 
essentially, all mice tested on days  11  and  14 showed hapten-augmentable  PFC.  The 144 
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Fla. 3.  Specificity  of hapten augmentation of plaque formation. Normal AKR/J mice received 4 
X  107 spleen cells from normal, or day-7 immune (10/.tg TNP-F), syngeneic donors together with 
10/~g TNP-F. Splenic direct anti-TNP PFC were assayed 4 d later. The effect of DNP-EACA (top 
panel) or TNP-EACA (bottom panel) on the number of PFC is shown. Hapten  concentration 
increases to the right. The number of direct PFC per spleen is indicated on the ordinate and the log 
of the reciprocal of the hapten concentration is indicated on the abscissa. The numbers at the top 
of the histograms indicate the percentage of augmentation of PFC at optimal hapten concentration 
as compared with the number of PFC in the absence of hapten. In each case, aliquots of the same 
spleen were used in hapten-augmentation studies with TNP-EACA and DNP-EACA (presented 
above one another). The number of PFC/spleen in the absence of hapten is indicated by the open 
bar. 
overall  average  percentage  of augmentation of PFC  remained relatively low  and 
constant with time after immunization in AKR/J  mice. In contrast, the data suggest 
that  there is an increase in the percentage of augmentation of PFC with time after 
immunization in BALB/c mice. 
However, the number of demonstrable auto-anti-idiotypic-antibody  blocked PFC 
cannot account for the decline in total PFC with time after immunization. There is, 
for instance, on days  11-14 of the response of AKR/J  mice, only a  26-30% increase 
in the number of observed PFC in the presence of hapten, whereas the decrease from 
the peak (day 4)  "observed" PFC response is 90%. 
Heterogeneity Indices of PFC during the Response to TNP-F.  An attempt was made to 
relate the above findings on blocked antibody-forming  cells to the decrease in apparent 
heterogeneity of antibody as measured by the conventional plaque inhibition assay 
(39).  In these  calculations, any hapten-augmentable PFC  were  purposely ignored. 
Within the limitations of this approach, a pattern of affinity maturation quite opposite F.  SCHRATER, E.  GOIDL, J.  THORBECKE, AND G.  SISKIND  145 
TABLE  II 
Relative Roles of T and B Cells in the Regulation of the Immune Response of Normal AKR/J Recipient 
Mice to TNP-F 
Direct anti-TNP PFC per spleen§  Percent- 
Number  age aug- 
Experi-  Donor cells*  Pretreat-  of cells in-  menta- 
ment  ment  jected:[:  Assayed with hap-  Assayed with  tion by 
ten absent  hapten present  hapten[[ 
1  Normal spleen  C 
Normal spleen  anti-thy 
I.I+C 
Immune spleen  C 
Immune spleen  anti-thy 
1.1+C 
X 10  v  % 
×  1.12  6  4  216,900 +  ×  1.13 (5)  230,600 + 
X  1.15  3  2.6  243,400 +  X  1.15 (5)  249,800 + 
×  1.06  47  4  139,600 +  X 1.03 (5)  205,800 + 
2.6  299,600 ×  1.12 (5)  426,600 ×  1.11  42  -4-  4- 
X  1.14  1  Normal spleen  C  2  240,500 +  X  1.13 (2)  242,500 + 
Immune spleen  C  2  189,900 +  ×  1.06 (3)  321,300 +X. 1.08  69 
Immune spleen  RAMB  1.2  349,300 ×  1.04 (3)  454,500 ×  1.0"/  30 
-1-  .-I- 
+C 
×  Y 
Normal serum  --  --  31,500  1.20  (5)  32,600  ~." 1.20  3  + 
(1 ml) 
×  1.23  189  Immune serum  --  --  3,800 +  ×  1.21 (5)  10,900  + 
(1 ml) 
* Spleen cells or serum from normal or immune AKR/J mice were transferred, together with 10 gg TNP- 
F, into normal mice (day 0). Immune donors had been injected with 10 gg TNP-F 7 d previously.  The 
data are presented as geometric means  ×/+  SE (number of animals studied). 
:~ l07 cells/ml were incubated either with C(1:18),  or together with anti-Thy 1.1  (1:60), or together with 
RAMB (1:50) for 45 min at 37°C. The number of cells transferred represent  the number of viable cells 
present (out of an initial 4.5  ×  107 cells per recipient) after treatment with these reagents. 
§ Assayed 3 d (experiment 3) or 4 d (experiments 1 and 2) after cell transfer. 
[[ Calculated as in Table I. 
to  that  usually  observed  with  T-dependent  antigens  was  found.  Rather  than  the 
expected  increase  in  heterogeneity  and  in  average  affinity with  time after  immuni- 
zation, a  decrease in both parameters was seen (Table IV). This decrease was, at least 
to some extent,  an  artifact  due  to  the simultaneous  presence  of PFC  inhibition  and 
augmentation.  Inhibition  curves obtained  with  DNP-EACA  showed a  much  greater 
decrease  in  apparent  heterogeneity  than  did  inhibition  curves obtained  with  TNP- 
EACA.  One  would  expect  that  the  heterogeneity  determinations  would  be  more 
affected by the augmentation  caused by the DNP  hapten, because this ligand required 
higher  concentrations  to  bring  about  an  augmentation  of PFC  than  did  the  TNP 
hapten  (Fig.  3).  Thus,  augmentation  by DNP-EACA  would be observed at  a  higher 
hapten  concentration,  and  the  observed  affinity  distribution  would  be  restricted, 
artificially, to the lower-affinity region of the curve. 
Hapten-concentration  dependence  of plaque  inhibition  is  influenced  by both  the 146  AUTO-ANTI-IDIOTYPIC ANTIBODY 
TABLr  III 
Augmentation by Hapten of Observed Anti-TNP Splenic PFC  from AKR/J and 
BALB/c Mice during the Primary Immune Response to TNP-F 
Strain  Assay day 
Incidence of > 10% aug-  Overall  average 
mentation*  percentage aug- 
mentation*  Ratio  Percentage 
AKR/~ 
%  % 
4  2/12  17  5 ±  1.2 
5  6/10  60  25 ±  5.4 
7  4/14  29  15 ±  6.14 
11  8/8  100  26 ±  2.47 
14  8/8  100  30 ±  5.3 
BALB/c  4  2/9  22  9 ±  3.3 
5  6/10  60  15 ±  4.1 
7  7/14  50  26 ±  8.6 
1l  9/9  I00  37 ±  5.3 
14  7/9  78  54 ±  15.3 
* Number of mice showing > 10% increase of PFC at optimal (3 ×  10  -a- 10  -6 
EACA) hapten concentration/total  number of mice tested. 
z~ Calculated as in Table I, and reported as mean :l: SE. 
M TNP- 
affinity  of the  antibody  for  the  inhibitor  and  the  rate  of antibody  secretion.  The 
conditions employed here (direct haptenation of erythrocytes at a  fairly high epitope 
density and the use of a  monovalent inhibitor)  probably result in an inhibition curve 
that  can  provide thermodynamic  information  (affinity);  however,  the conditions of 
the assay have not been optimized for obtention of affinity data (47). For the purposes 
of the present studies, the slight uncertainty introduced is not significant because the 
main  concern  is  not  with  hapten  inhibition  or  affinity,  but,  rather,  with  hapten 
augmentation of PFC. Within the limits of the techniques used, it appeared  that the 
decreases  in affinity and  heterogeneity after  the peak of the  immune response were 
caused by the in vivo inhibition of, and resulting inability to detect, in vitro, as PFC, 
a  subset  of antibody-synthesizing cells, due to the presence of an auto-anti-idiotypic 
response. 
Discussion 
Numerous  studies  indicate  that  important  immuno-regulatory  effects  can  be ob- 
tained  by deliberate  immunization  with  idiotypes  (4,  16,  17,  19,  48,  49).  Although 
several observations concerning spontaneous,  production of auto-anti-idiotypic anti- 
body have been made (13-19, 50), no definitive evidence for their regulatory effect in 
vivo  has  been  obtained.  Taken  in  conjunction  with  the  results  reported  in  the 
accompanying paper  (32), which provide direct evidence for the auto-anti-idiotypic- 
antibody  nature  of the  inhibitory  factor  studied  here,  the  present  report  argues 
strongly  in  favor  of  the  auto-regulatory  effect  of  such  antibodies,  as  originally 
suggested by Jerne  (1).  In the accompanying paper  (32), it has been shown that  the 
auto-anti-idiotypic antibody present in immune sera can block secretion of anti-TNP 
antibody by PFC in vitro.  In this paper,  it was shown that blocked PFC are present 
in  immune mice at  a  time when  both  the  magnitude  of the  PFC response and  the 
apparent  heterogeneity  of  PFC  with  respect  to  antibody  affinity  are  decreasing 
rapidly. F.  SCHRATER,  E.  GOIDL,  J.  THORBECKE,  AND  G.  SISKIND 
TABLE IV 
Comparison of Shannon Heterogeneity Indices Obtained with TNP-EACA and 
DNP-EACA as Inhibitors of Splenic Direct anti-TNP PFC at  Various Days 
after Pnmaol Immunization of AKR/J Mice with TNP-F 
Days after im- 
munization 
Heterogeneity index* 
TNP-EACA  DNP-EACA 
4  2.14  :k  0.06 (7)  1.54  -4- 0.21  (9) 
5  1.79  :[: 0.10 (10)  ND$ 
7  1.67  :k 0.08 (23)  ND 
11  1.¢52:1:0.07  (6)  0.02  st: 0.02 (6) 
* Hapten inhibition of PFC data obtained at various days after intravenous 
injection of 10 #g TNP-F. Heterogeneity is expressed as the Shannon index 
(42) and presented as mean :t: SE (number of animals studied). In calculation 
of these indices any augmentation of PFC by hapten was purposely ignored. 
:[: ND, not done. 
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The precipitous decline in the number of PFC/spleen between days 4 and 7 of the 
primary immune response has not been observed by other investigators who studied 
the response to intraperitoneally injected DNP-F  in other strains of mice  (29,  31). 
TNP-F-anti-TNP-F immune complexes might be responsible for the induction of an 
auto-anti-idiotypic response (51, 52).  Because such complexes are likely to be more 
prominent after intravenous than after intraperitoneal immunization, there might be 
an influence of route of antigen injection on this phenomenon. There also might be 
strain differences in the number of idiotypes specific for the TNP hapten or in their 
quantitative representation in the immune response that, in turn, could influence the 
anti-idiotypic response. Such differences are illustrated in the present paper in that 
the decline in the number of PFC/spleen and in heterogeneity (Fig. 1 and unpublished 
observations) was less marked in BALB/c than in AKR/J mice. It could be inferred 
from these observations that the humoral immune response of AKR/J mice to TNP- 
F  involves a  major idiotype specific for the TNP hapten.  It  is of interest  that  the 
isoelectric-focusing spectra of serum antibody from individual AKR/J  mice immu- 
nized with 2,4,-dinitrophenyl-lys-Ficoll (DNP-F)  are severely restricted and  display 
identical patterns as compared to the marked heterogeneity of anti-DNP-F antibody 
from individual C57BL/6 micefl 
Although  the  auto-anti-idiotypic  response  occurs  in  both  AKR/J  and  BALB/c 
mice, studies with sera from both strains (unpublished data) indicate that the response 
occurs earlier and  reaches higher serum  levels  in  the  AKR/J  strain.  Hapten-aug- 
mentable  PFC  are clearly present  in both strains  after the peak of the response to 
TNP-F (Table III), and may actually be more numerous in BALB/c, possibly due to 
the more prolonged nature of the auto-anti-idiotypic response and (or) because of the 
absence of a  major idiotype to TNP  in  this  strain.  Preliminary observations  in  a 
number of other strains and with other thymus-independent and thymus-dependent 
TNP conjugates suggest that the occurrence of hapten-augmentable PFC during the 
anti-TNP response of mice may be a  universal phenomenon,  a Further experiments 
are  needed  to  determine whether similar  (cross-reactive) or different idiotypes are 
'~' Zitron, I. Personal communication. 
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involved in the immune responses of AKR/J and BALB/c mice to TNP-F. There are 
several descriptions of cross-reactive idiotypes (49, 53-56); the majority are linked to 
genes coding for heavy-chain allotypes (57), although some are not (56, 58, 59). 
The unblocking of PFC by displacement of anti-idiotype was observed with both 
TNP- and DNP-EACA. The greater effectiveness of the TNP hapten probably reflects 
the known, fine-specificity differences of anti-TNP antibodies and cell receptors for 
these  haptens  (60,  61).  Another  interesting  observation  is  that  the  peak  hapten 
augmentation of AKR/J anti-TNP PFC usually occurred between 3  ×  10  -9 and  1 
×  10  -7 M  hapten, whereas with BALB/c anti-TNP PFC it occurred between  1  × 
10  -~ and 1 ×  10  -6 M TNP-EACA. This might reflect subtle differences between these 
strains in their idiotype-anti-idiotype interactions or'in the affinity of their antibody 
for the haptenic determinant. 
The results presented here indicate that transfer into normal AKR/J mice of day- 
7  immune  serum,  or splenic  B  cells  plus  TNP-F,  led  to  an  earlier appearance of 
hapten-augmentable  PFC  than  did  immunization  with  TNP-F  alone.  However, 
immune B cells alone did not appear to transfer suppression because, in recipients of 
T-cell-depleted immune spleen cells, the numbers of PFC detected in the presence or 
absence of hapten was equal to, or greater than, what was observed in the response of 
mice that received normal cells plus antigen. Apparently, anti-TNP immune B cells 
could add to the magnitude of the response of normal recipients only when immune 
T  cells were excluded from the donor population. The inclusion of day-7 immune T 
cells led to a decrease in the combined response of donor and recipient B cells. T cells 
could have several roles in  this phenomenon.  Firstly, they may simply function as 
helper T  cells in  the induction  and  height of the anti-idiotypic-antibody response, 
which is clearly suggested by the observation that congenitally athymic, homozygous 
for the recessive gene nu (nu/nu) AKR/J mice do not make a detectable anti-idiotypic 
response.  4 Additional  evidence for this supposition  comes  from work showing that 
mice depleted of T  cells fail to make anti-idiotypic antibody to a  myeloma protein 
(62), indicating that the response to this protein antigen is T-dependent as might be 
expected. The existence of idiotype-specific helper T  cells has recently been demon- 
strated (63). It could be postulated that such cells also operate as helper cells for the 
anti-idiotypic response. Secondly, an idiotype-specific suppressor T  cell may also be 
involved in the suppression described here, for which there are many precedents (16, 
19, 20, 48, 49). Further experiments are needed to determine the exact nature of the 
T-cell involvement in these studies. 
The earliest  indication of regulation  by anti-idiotypic antibody may be the ap- 
pearance of hapten-augmentable PFC. Regulation by relatively minor anti-idiotypic 
responses might  go undetected without  a  specific examination  for the  presence of 
blocked, hapten-augmentable PFC. Hapten-augmentable PFC were, in fact, present 
in the primary response of mice to phosphorylcholine (PC) in studies by Cosenza and 
K6hler (8), although their significance was not discussed. Because day-7 immune B 
cells  greatly accelerated the  appearance of hapten-augmentable  PFC,  the anti-idi- 
otypic response must  have occurred almost immediately after the peak of the anti- 
4  Schrater, A. F., E. A. Goidl, G. J. Thorbecke, and G. W. Siskind. Production of auto-anti-idiotypic 
antibody during the normal immune response to TNP-Ficoll. III. Absence of regulation by auto-anti- 
idiotypic antibody in nu/nu mice. Manuscript in preparation. F.  SCHRATER, E. GOIDL, J. THORBECKE, AND G. SISKIND  149 
TNP-F response (Table I). This is consistent with data in the accompanying paper 
showing  the  presence of anti-idiotypic antibody  in  day-7  immune  serum  (32).  In 
contrast, during the response to PC, the auto-anti-idiotypic antibody was detected in 
serum  only after repeated  immunizations  (13).  Cosenza  (14)  found that  the  anti- 
idiotypic (anti-anti-PC) PFC response peaked, in the spleen, 3 d after the peak of the 
secondary PFC response to Pneumococcus R36A vaccine. The rapidity of the auto-anti- 
idiotypic response  in  AKR/J  mice  may be  due  to  their unusually high  antibody 
response to TNP-F. It is also possible that  relatively nondegradable polysaccharide 
antigens  might  favor  the  induction  of auto-anti-idiotypic  responses,  because  the 
persisting  complexes  of  antigen  and  antibody  (idiotype)  are  likely  to  be  more 
immunogenic than is the idiotype present on cell surfaces, or free in the circulation 
(51, 52). 
These results support the view, proposed by Tasiaux et al.  (20)  and Urbain  (25), 
that the fall in antibody affinity during the primary and secondary immune responses 
may be due to regulation by auto-anti-idiotype. It is likely that in the present studies, 
at least part of the decrease in PFC affinity and heterogeneity is artifactual, and is the 
result of the hapten-augmented PFC obscuring the presence of high-affinity PFC that 
would  otherwise  have  been  observed  in  the  low-hapten-concentration end  of the 
inhibition  curve.  However, others  (24,  35)  have detected, by equilibrium  analysis, 
similar affinity changes in serum antibody. 
Hapten inhibition of plaque formation has been used by many workers as an assay 
of antibody affinity since it was first described by Andersson  (39). Both correlative 
studies and mathematical analysis (40)  indicate that a valid estimate of affinity can 
be obtained in this manner. When this method has previously been employed in our 
laboratory, we have often noted a modest (<20%) augmentation of plaque formation 
at  low hapten  concentrations.  Because,  in  most  cases, the  5  or  10%  augmentation 
observed was within experimental error, it was ignored. Furthermore, augmentation 
of the minimal  degree usually seen in anti-hapten responses doses not significantly 
alter the affinity-distribution curve calculated from the hapten data.  When, in the 
cell-transfer studies described here, hapten augmentation of PFC  far exceeded any 
conceivable experimental error, it became apparent that a  real phenomenon existed 
that required precise explanation. The results reported in this and the accompanying 
(32) papers provide evidence that hapten augmentation of PFC is due to displacement 
of auto-anti-idiotypic antibody and can be used as an assay for the presence of such 
antibodies.  Finally,  the  data  point  out  a  potential  hazard  in  the  use  of hapten 
inhibition of plaque formation as an assay of antibody affinity. Clearly, when marked 
hapten  augmentation  of plaque  formation is  present, hapten  inhibition cannot  be 
directly used as an assay for affinity distributions. 
Summary 
Attempts  were  made  to  elucidate  the  cause of the  downward  regulation of the 
splenic plaque-forming cell  (PFC)  response in  AKR/J  and  BALB/c mice between 
days  4  and  7  after a  single  intravenous  injection of 2,4,6,trinitrophenyl-lys-Ficoll 
(TNP-F). AKR/J spleen cells, taken  7 d  after injection of TNP-F, were transferred, 
together with TNP-F, into normal AKR/J mice. The day-3 or -4 PFC response of the 
recipients was  much  lower than  that  of recipients  of normal  cells.  However, the 
suppression was  only apparent because the presence of 10-8-10  -7 M  2,4,6-trinitro- 150  AUTO-ANTI-IDIOTYPIC  ANTIBODY 
phenyl-~-amino-n-caproic acid  (TNP-EACA)  (or  10-7-10  -6 M  2,4,-dinitrophenyl-E- 
amino-n-caproic acid) in the PFC assay caused a dramatic increase in observed PFC, 
averaging 298%  on day 3 and  122% on day 4.  Recipients of normal cells  showed no 
such  hapten-augmentable PFC.  T-depleted  immune spleen  cells  did  not cause any 
apparent  suppression  of the  response  to  TNP-F,  but  hapten-augmentable  PFC  in 
recipient  spleens were again prevalent.  Suppression of the PFC response, as well as 
hapten-augmentable PFC, were seen after transfer of  immune serum. It was postulated 
that hapten augmentation of PFC was caused by displacement of auto-anti-idiotypic 
antibody from the surface of blocked antibody-synthesizing cells. 
Further studies showed that such hapten-augmentable PFC occurred in the spleens 
of a  large percentage of both AKR/J and BALB/c mice examined after day 4 of the 
primary response to TNP-F. Thus, it was hypothesized that the downward regulation 
of the magnitude and, possibly, also of the heterogeneity of the splenic-PFC response 
was due to an auto-antibody response to one or more major idiotypes of the anti-TNP 
response. 
We wish to thank Judith Chapman-Alexander,  Margaret  Groves, and Nancy Martinez for 
excellent technical assistance. 
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